Novartis AG
Patents, Design & Utilities
Last updated:
List of all Novartis AG patents 1,223 in total
| Status | Patent |
|---|---|
Application | Utility: 5-HYDROXY-7-OXABICYCLO[2.2.1]HEPTANE-2-CARBOXAMIDE DERIVATIVES FOR INDUCING CHONDROGENESIS FOR TREATING JOINT DAMAGE Filling date: 23 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: N-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE DERIVATIVES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 10 Mar 2022 |
Grant | Utility: Combination therapy Filling date: 23 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Apparatus and method for producing a flow profile Filling date: 23 Sep 2025 Issue date: 8 Mar 2022 |
Application | Utility: TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR Filling date: 23 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: 1,2,4-OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS Filling date: 23 Sep 2025 Issue date: 3 Mar 2022 |
Grant | Utility: Surgical instrument using detected light Filling date: 23 Sep 2025 Issue date: 1 Mar 2022 |
Application | Utility: USE OF IL-1BETA BINDING ANTIBODIES Filling date: 23 Sep 2025 Issue date: 24 Feb 2022 |
Grant | Utility: NLRP3 inflammasome inhibitors Filling date: 23 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Weekly and monthly disposable water gradient contact lenses Filling date: 23 Sep 2025 Issue date: 22 Feb 2022 |
Application | Utility: CD22 CHIMERIC ANTIGEN RECEPTOR (CAR) THERAPIES Filling date: 23 Sep 2025 Issue date: 17 Feb 2022 |
Grant | Utility: Computer method and system for deriving cell-to-cell spatial proximities Filling date: 23 Sep 2025 Issue date: 15 Feb 2022 |
Grant | Utility: Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate Filling date: 23 Sep 2025 Issue date: 15 Feb 2022 |
Grant | Utility: Surgical tool attachment systems and method of use Filling date: 23 Sep 2025 Issue date: 15 Feb 2022 |
Application | Utility: Amino Pyrimidine Derivatives Filling date: 23 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: ANTIBODY-CYTOKINE ENGRAFTED PROTEINS AND METHODS OF USE FOR IMMUNE RELATED DISORDERS Filling date: 23 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: Fused Tricyclic Pyridazinone Compounds Useful to Treat Orthomyxovirus Infections Filling date: 23 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: SOLID FORMS OF N-(4-FLUORO-3-(6-(3-METHYLPYRIDIN-2-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-2- -YL)PHENYL)-2,4-DIMETHYLOXAZOLE-5-CARBOXAMIDE Filling date: 23 Sep 2025 Issue date: 10 Feb 2022 |
Grant | Utility: Mesenchymal stem cell differentiation Filling date: 23 Sep 2025 Issue date: 8 Feb 2022 |
Grant | Utility: Eukaryotic cells and methods for recombinantly expressing a product of interest Filling date: 23 Sep 2025 Issue date: 8 Feb 2022 |
Application | Utility: ORGANIC COMPOUNDS Filling date: 23 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: SYRINGE Filling date: 23 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: Dose and regimen for an hdm2-p53 interaction inhibitor in hematological tumors Filling date: 23 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: N-(pyridin-2-ylsulfonyl)cyclopropanecarboxamide Derivatives and their Use in the Treatment of Disease Filling date: 23 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: 6-HYDROXY-8-OXATRICYCLO[3.2.1.02,4]OCTANE-2-CARBOXAMIDE DERIVATIVES FOR INDUCING CHONDROGENESIS FOR TREATING JOINT DAMAGE Filling date: 23 Sep 2025 Issue date: 3 Feb 2022 |
Grant | Utility: Methods for treating ocular surface pain Filling date: 23 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Chemical process Filling date: 23 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals Filling date: 23 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Catalysts for chemical reactions in a water-surfactant mixture Filling date: 23 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Reaction medium containing water-surfactant mixture Filling date: 23 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Methods of treating FGF21-associated disorders Filling date: 23 Sep 2025 Issue date: 1 Feb 2022 |
Application | Utility: ANTI-BETACELLULIN ANTIBODIES, FRAGMENTS THEREOF, AND MULTI-SPECIFIC BINDING MOLECULES Filling date: 23 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: USE OF IL-1BETA BINDING ANTIBODIES Filling date: 23 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: REVERSAL BINDING AGENTS FOR ANTI-FACTOR XI/XIA ANTIBODIES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: CYCLIC PEPTIDES AS PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) INHIBITORS FOR THE TREATMENT OF METABOLIC DISORDERS Filling date: 23 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: LPL-GPIHBP1 FUSION POLYPEPTIDES Filling date: 23 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: Multi-Copy Gene Protein Expression System Filling date: 23 Sep 2025 Issue date: 27 Jan 2022 |
Grant | Utility: 1,4-disubstituted pyridazine analogs thereof and methods for treating SMN-deficiency-related conditions Filling date: 23 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Combinations of FGFR4 inhibitors and bile acid sequestrants Filling date: 23 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Optimized expression cassette for expressing a polypeptide with high yield Filling date: 23 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Methods for treating gastrointestinal disorders using FXR agonists Filling date: 23 Sep 2025 Issue date: 25 Jan 2022 |
Application | Utility: METHODS OF USING FACTOR B INHIBITORS Filling date: 23 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: SIP MODULATOR IMMEDIATE RELEASE DOSAGE REGIMEN Filling date: 23 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: COMBINATION OF A MCL-1 INHIBITOR AND MIDOSTAURIN, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF Filling date: 23 Sep 2025 Issue date: 20 Jan 2022 |
Grant | Utility: Coated forceps for improved grasping Filling date: 23 Sep 2025 Issue date: 18 Jan 2022 |
Application | Utility: TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY A BETA-BLOCKER Filling date: 23 Sep 2025 Issue date: 13 Jan 2022 |
Grant | Utility: Enzymatic reaction medium containing surfactant Filling date: 23 Sep 2025 Issue date: 11 Jan 2022 |
Application | Utility: LFA-1 INHIBITOR FORMULATIONS Filling date: 23 Sep 2025 Issue date: 6 Jan 2022 |
Grant | Utility: Thermally robust multi-spot laser probe Filling date: 23 Sep 2025 Issue date: 4 Jan 2022 |
Grant | Utility: NLRP3 inflammasome inhibitors Filling date: 23 Sep 2025 Issue date: 28 Dec 2021 |
Showing 150 to 200 of 1223 patents.